Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterial cell envelope lipids are a complex and unique set of lipid molecules that constitute the outer membrane, or mycomembrane, of Mycobacteria species, including Mycobacterium tuberculosis (Brennan, 2003, PMID: 14551230). These lipids, most notably mycolic acids, are long-chain fatty acids that provide a dense, waxy barrier, making the bacteria highly resistant to environmental stress, chemical disinfectants, and many common antibiotics (Nikaido, 2003, PMID: 12624055). Beyond their structural role, these lipids act as potent virulence factors that modulate the host's immune response, allowing the pathogen to survive within macrophages (Gilleron et al., 2008, PMID: 18463157). Targeting the biosynthesis of these lipids is a cornerstone of tuberculosis therapy, as seen with drugs like isoniazid and ethionamide which inhibit the enoyl-ACP reductase InhA, a key enzyme in mycolic acid production (Vilchèze & Jacobs, 2007, PMID: 17661707). Disruption of this lipid layer leads to increased cell permeability and bacterial death. Understanding the diversity of these lipids is crucial for developing new diagnostics, such as the detection of lipoarabinomannan (LAM) in urine, and therapeutic strategies against mycobacterial infections (Peter et al., 2012, PMID: 22410214).
Inhibition of mycolic acid biosynthesis (e.g., via InhA inhibition) and disruption of the assembly of the mycobacterial mycomembrane.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial cell envelope lipids.